Search

everythinglearnresearchcommunity

for

Search:↓

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

People with all types of psoriasis are more likely to have autoimmune diseases than those without psoriasis.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

A young child with alopecia areata and psoriasis improved with treatment, suggesting a link between the two conditions.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

A woman's hair grew back while she was taking sulphasalazine for arthritis.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

Early recognition and treatment of severe SLE symptoms can improve outcomes.

A young woman with visual issues and other symptoms was diagnosed with lupus and antiphospholipid syndrome, and improved with treatment.

The boy's symptoms suggest a possible new medical condition.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

The child was diagnosed with a skin condition involving inflamed hair follicles.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Glucocorticoid treatment improved symptoms in a girl with Satoyoshi disease.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.